Charitable Pharmacies of America organization member receives Health Equity grant
Related Posts

NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.

Want to learn more about Free and Charitable Clinics, Charitable Pharmacies and the medically underserved?

There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.

In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it

How Many People Might Lose Medicaid When States Unwind Continuous Enrollment?

We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…

Charitable Pharmacies of America organization member receives Health Equity grant

FDA approves 1 Year delay of Track & Trace requirements

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Implications for Patients
Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected

One in four Americans say they struggle to afford their prescription medications. The establishment of this Charitable Pharmacy in Milford will allow patients who live east of Cincinnati better access to care.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Around one fourth of the United States population does not have adequate health literacy.
Health literacy is defined as the ability to obtain, read, understand, and apply healthcare
information

APPLICATIONS ARE OPEN! – Letters of Intent due 9/15/23

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections